The Global Alliance for Transplantation

1. Introduction

Organ transplantation is a successful therapy for end stage organ failure of the kidney, liver, heart, lung, pancreas and intestine. Transplantation of cells and tissues has also transformed the therapeutic options for patients with malignant haematological disease, eye disease and orthopaedic disease, and has the potential to alter significantly the therapeutic options for patients with diabetes and a range of disorders.

The access of patients to transplantation therapy varies widely across the globe, partly determined by the underlying level of economic development in different states and partly determined by other factors such as the availability of organ, cell and tissue donors, or the specialist provision of health services.

The Transplantation Society has determined that it will seek to address global inequities in transplantation therapy, in order to facilitate appropriate access to transplantation for all patients who would benefit.

Table – Transplantation of organs in different continents/regions year 2000

  Kidney
(pmp*)
Liver
(pmp)
Heart
(pmp)
USA 52 19 8
Europe 27 10 4
Asia 3 0,3 0,03
Latin America 13 1,6 0,5
*Per million population

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi